Effect of Vitamin D3 and Omega-3FA on Leptin and HbA1C With Vitamin D Deficiency
NCT ID: NCT03735303
Last Updated: 2019-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
146 participants
INTERVENTIONAL
2018-12-01
2019-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Combined Effect of Omega-3 Fatty Acid and Vitamin D3 on Lipid Profile Levels and Oxidized Low Density Lipoprotein
NCT04005573
The Effects of Vitamin D3 Alone and in a Combination With Omega-3 on the Association of C-peptide With Glycemic Control
NCT04307784
The Effect of Omega 3 on 25 Hydroxyvitamin D
NCT04174625
Effect of Weekly High-dose Vitamin D3 Supplementation on the Association Between Circulatory FGF-23 and A1c Levels
NCT04682626
Vitamin D3 Treatment and Homocysteine Concentrations Among Overweight Reproductive Women
NCT03310307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will be conducted to investigate effect of VD3 and omega-3FA alone and with each other on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.
This randomized, controlled clinical trial will be designed to test effects of 50,000 IU VD3 weekly and 1000 mg omega-3FA daily for eight weeks, separately and with each other, on on serum leptin and Glycated hemoglobin (Hb A1C) levels .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VD3 group
dietary supplement : VD3 group treated with 50000 IU VD3/ week for 8 weeks
VD3 group
VD3 50000 IU/ week for 8 weeks
omega 3- FA group
dietary supplement : omega 3- FA group 1000 mg wild salmon and fish oil complex (contain 300 mg of omega 3-FA) once daily for 8 weeks
omega 3 FA group
omega 3 FA group 300 mg once daily for 8 weeks
VD3 and omega 3 FA group
dietary supplement : VD3 and omega-3FA 50000 IU VD3/week for 8 weeks and 1000 mg wild salmon and fish oil complex (contain 300 mg of omega 3-FA) once daily for 8 weeks
VD3 and omega- 3FA group
50000 IU VD3/week for 8 weeks and 300 mg of omega- 3 FA once daily for 8 weeks
control group
no intervention was given
control group
no intervention was given
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VD3 group
VD3 50000 IU/ week for 8 weeks
omega 3 FA group
omega 3 FA group 300 mg once daily for 8 weeks
VD3 and omega- 3FA group
50000 IU VD3/week for 8 weeks and 300 mg of omega- 3 FA once daily for 8 weeks
control group
no intervention was given
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* medical diagnosis of vitamin D deficiency ( VD \<25 ng/ ml)
Exclusion Criteria
* thalassemia
* sickle cell disease
25 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Applied Science Private University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud S Abu-Samak, PhD
Role: PRINCIPAL_INVESTIGATOR
Applied Science Private University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Applied Science University
Amman, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ross AC. The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr. 2011 May;14(5):938-9. doi: 10.1017/S1368980011000565. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DRGS-4-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.